COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol is a clinical trial[1].
Key Facts
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol is in the country of United States[2].
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol's instance of is recorded as clinical trial[3].
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol's start time is recorded as +2021-04-23T00:00:00Z[4].
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol's end time is recorded as +2022-08-31T00:00:00Z[5].
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol's main subject is recorded as pneumonia[6].
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol's main subject is recorded as COVID-19[7].
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol's number of participants is recorded as {'unit': '1', 'amount': '+240'}[8].
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol's title is recorded as COVID-19 Outpatient Pragmatic Platform Study (COPPS): A Pragmatic Multi-arm, Adaptive, Phase 2, Blinded, Randomized Placebo-controlled Platform Trial to Assess the Efficacy of Different Investigational Therapeutics in Reducing Time to Disease Resolution or Viral Load Cessation, as Compared to Standard Supportive Care in Outpatients With COVID-19[9].
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[10].
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol's ClinicalTrials.gov ID is recorded as NCT04662086[11].
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+80'}[12].
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol's research intervention is recorded as camostat[13].
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol's research intervention is recorded as enzyme inhibitor[14].
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol's research intervention is recorded as mechanism of action[15].
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol's research intervention is recorded as serine proteinase inhibitor[16].
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol's clinical trial phase is recorded as phase II clinical trial[17].
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol's research site is recorded as Stanford University[18].
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol's research subject recruitment status is recorded as recruiting[19].
- COVID-19 Outpatient Pragmatic Platform Study (COPPS) - Master Protocol's study type is recorded as interventional study[20].